Inflammatory process and aging.
In my previous post, Aspirin and aging, I hypothesize inflammation in the aging process.
Alzheimer's disease (AD) is an aging disease. Aspirin can reduce the incidence of Alzheimer's disease. So it is possible that inflammation is involved in the pathogenesis of Alzheimer's disease.
There are recent studies indicating C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease (AD). The present results further support an involvement of inflammatory processes in the etiology of AD.
C-reactive protein is elevated in the inflammatory diseases.
So prevention of Alzheimer's disease by aspirin is based on its anti-inflammatory pharmacological mechanism.